Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 3, 2024Inflammatory Bowel Diseases

Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

OLOren LedderMDMichael T. DolingerMDMarla C. Dubinsky

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ledder et al. (2024) studied this question.

synapsesocial.com/papers/68e665f2b6db6435875f2194https://doi.org/10.1093/ibd/izae112
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis2017 · 1,774 citations
  2. 2Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program2022 · 14 citations
  3. 3Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment2021 · 156 citations
  4. 4Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry2020 · 103 citations
  5. 5Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis2018 · 185 citations